25 XP   0   0   10

Crescita Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Crescita Therapeutics Inc together

PenkeI guess you are interested in Crescita Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Crescita Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Crescita Therapeutics Inc

I send you an email if I find something interesting about Crescita Therapeutics Inc.

Quick analysis of Crescita Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Crescita Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.94
Expected worth in 1 year
C$0.86
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
C$-0.08
Return On Investment
-18.3%

For what price can you sell your share?

Current Price per Share
C$0.44
Expected price per share
C$0.42 - C$0.49
How sure are you?
50%

1. Valuation of Crescita Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

C$0.44

Intrinsic Value Per Share

C$-2.29 - C$-2.75

Total Value Per Share

C$-1.34 - C$-1.80

2. Growth of Crescita Therapeutics Inc (5 min.)




Is Crescita Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$13.6m$14.7m-$299k-2.1%

How much money is Crescita Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$360.6k$95.7k-$456.3k-126.5%
Net Profit Margin-14.2%1.8%--

How much money comes from the company's main activities?

3. Financial Health of Crescita Therapeutics Inc (5 min.)




What can you expect buying and holding a share of Crescita Therapeutics Inc? (5 min.)

Welcome investor! Crescita Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Crescita Therapeutics Inc.

What can you expect buying and holding a share of Crescita Therapeutics Inc?

First you should know what it really means to hold a share of Crescita Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Crescita Therapeutics Inc is C$0.435. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Crescita Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Crescita Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.94. Based on the TTM, the Book Value Change Per Share is C$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Crescita Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-1.3%-0.02-4.1%0.011.8%0.00-0.2%-0.04-9.9%
Usd Book Value Change Per Share0.000.8%-0.01-3.3%0.011.4%0.000.2%0.024.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.8%-0.01-3.3%0.011.4%0.000.2%0.024.4%
Usd Price Per Share0.36-0.44-0.49-0.49-0.50-
Price to Earnings Ratio-16.30--10.67--20.52--0.77--0.81-
Price-to-Total Gains Ratio97.92-77.51-87.37-309.71-194.46-
Price to Book Ratio0.52-0.62-0.69-0.70-0.66-
Price-to-Total Gains Ratio97.92-77.51-87.37-309.71-194.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.315984
Number of shares3164
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (3164 shares)-45.812.61
Gains per Year (3164 shares)-183.2310.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-183-1930100
20-366-37602110
30-550-55903120
40-733-74204230
50-916-92505240
60-1099-110806350
70-1283-129107360
80-1466-147408370
90-1649-165709480
100-1832-1840010490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%7.013.00.035.0%10.026.00.027.8%10.026.00.027.8%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%10.010.00.050.0%16.017.03.044.4%16.017.03.044.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%0.00.036.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%10.010.00.050.0%16.017.03.044.4%16.017.03.044.4%

Fundamentals of Crescita Therapeutics Inc

About Crescita Therapeutics Inc

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription portfolio offers dermocosmetic products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare to treat mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea under the Laboratoire Dr Renaud brand; and provides medical aesthetics under Pro-Derm and Alyria brands, for non-invasive and minimally invasive procedures or skincare treatments. In addition, it distributes NCTF Boost 135 HA, a skin revitalization solution; Obagi Medical products; and ART FILLER, hyaluronic acid-based dermal fillers. The company has a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.

Fundamental data was last updated by Penke on 2024-04-10 02:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Crescita Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Crescita Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -3.2% means that $-0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Crescita Therapeutics Inc:

  • The MRQ is -3.2%. The company is making a loss. -1
  • The TTM is -14.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3.2%TTM-14.2%+11.0%
TTM-14.2%YOY1.8%-16.0%
TTM-14.2%5Y-12.3%-1.9%
5Y-12.3%10Y-575.1%+562.8%
1.1.2. Return on Assets

Shows how efficient Crescita Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.6% Return on Assets means that Crescita Therapeutics Inc generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Crescita Therapeutics Inc:

  • The MRQ is -0.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-1.9%+1.3%
TTM-1.9%YOY0.5%-2.4%
TTM-1.9%5Y-0.3%-1.6%
5Y-0.3%10Y-12.6%+12.3%
1.1.3. Return on Equity

Shows how efficient Crescita Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.8% Return on Equity means Crescita Therapeutics Inc generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Crescita Therapeutics Inc:

  • The MRQ is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-2.5%+1.7%
TTM-2.5%YOY0.6%-3.1%
TTM-2.5%5Y-0.4%-2.1%
5Y-0.4%10Y-3.5%+3.1%

1.2. Operating Efficiency of Crescita Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Crescita Therapeutics Inc is operating .

  • Measures how much profit Crescita Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Crescita Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.4%+0.4%
TTM-0.4%YOY2.3%-2.7%
TTM-0.4%5Y-6.8%+6.4%
5Y-6.8%10Y-574.1%+567.3%
1.2.2. Operating Ratio

Measures how efficient Crescita Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are $1.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Crescita Therapeutics Inc:

  • The MRQ is 1.376. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.459. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.376TTM1.459-0.083
TTM1.459YOY0.982+0.477
TTM1.4595Y1.111+0.349
5Y1.11110Y5.879-4.768

1.3. Liquidity of Crescita Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Crescita Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.80 means the company has $3.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Crescita Therapeutics Inc:

  • The MRQ is 3.801. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.757. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.801TTM3.757+0.044
TTM3.757YOY3.081+0.675
TTM3.7575Y3.533+0.224
5Y3.53310Y3.297+0.236
1.3.2. Quick Ratio

Measures if Crescita Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.24 means the company can pay off $0.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Crescita Therapeutics Inc:

  • The MRQ is 0.245. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.019. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.245TTM2.019-1.775
TTM2.019YOY2.215-0.195
TTM2.0195Y2.522-0.502
5Y2.52210Y2.684-0.162

1.4. Solvency of Crescita Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Crescita Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Crescita Therapeutics Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.23 means that Crescita Therapeutics Inc assets are financed with 23.5% credit (debt) and the remaining percentage (100% - 23.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Crescita Therapeutics Inc:

  • The MRQ is 0.235. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.239. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.239-0.004
TTM0.239YOY0.285-0.046
TTM0.2395Y0.267-0.028
5Y0.26710Y0.363-0.095
1.4.2. Debt to Equity Ratio

Measures if Crescita Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 30.7% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Crescita Therapeutics Inc:

  • The MRQ is 0.307. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.314. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.314-0.008
TTM0.314YOY0.400-0.086
TTM0.3145Y0.369-0.054
5Y0.36910Y0.373-0.004

2. Market Valuation of Crescita Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Crescita Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Crescita Therapeutics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -16.30 means the investor is paying $-16.30 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Crescita Therapeutics Inc:

  • The EOD is -14.468. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.297. Based on the earnings, the company is expensive. -2
  • The TTM is -10.666. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.468MRQ-16.297+1.829
MRQ-16.297TTM-10.666-5.631
TTM-10.666YOY-20.520+9.854
TTM-10.6665Y-0.767-9.899
5Y-0.76710Y-0.812+0.045
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Crescita Therapeutics Inc:

  • The EOD is -5.929. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.679. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 17.187. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-5.929MRQ-6.679+0.750
MRQ-6.679TTM17.187-23.866
TTM17.187YOY-6.632+23.818
TTM17.1875Y44.286-27.100
5Y44.28610Y23.707+20.579
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Crescita Therapeutics Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Crescita Therapeutics Inc:

  • The EOD is 0.461. Based on the equity, the company is cheap. +2
  • The MRQ is 0.520. Based on the equity, the company is cheap. +2
  • The TTM is 0.617. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.461MRQ0.520-0.058
MRQ0.520TTM0.617-0.097
TTM0.617YOY0.695-0.078
TTM0.6175Y0.700-0.083
5Y0.70010Y0.661+0.039
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Crescita Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.005-0.020+498%0.008-41%0.001+341%0.026-81%
Book Value Per Share--0.9430.980-4%0.973-3%0.966-2%0.898+5%
Current Ratio--3.8013.757+1%3.081+23%3.533+8%3.297+15%
Debt To Asset Ratio--0.2350.239-2%0.285-18%0.267-12%0.363-35%
Debt To Equity Ratio--0.3070.314-2%0.400-23%0.369-17%0.373-18%
Dividend Per Share----0%-0%-0%-0%
Eps---0.008-0.024+225%0.011-172%-0.001-82%-0.059+685%
Free Cash Flow Per Share---0.0180.024-177%-0.015-16%0.021-186%-0.047+158%
Free Cash Flow To Equity Per Share---0.0310.012-368%-0.037+20%0.002-1865%0.021-249%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.745--------
Intrinsic Value_10Y_min---2.286--------
Intrinsic Value_1Y_max---0.057--------
Intrinsic Value_1Y_min---0.056--------
Intrinsic Value_3Y_max---0.337--------
Intrinsic Value_3Y_min---0.319--------
Intrinsic Value_5Y_max---0.818--------
Intrinsic Value_5Y_min---0.745--------
Market Cap8500509.000-15%9778153.84012262066.323-20%14056520.093-30%14237334.851-31%14076073.577-31%
Net Profit Margin---0.032-0.142+347%0.018-281%-0.123+287%-5.751+18016%
Operating Margin----0.0040%0.023-100%-0.0680%-5.7410%
Operating Ratio--1.3761.459-6%0.982+40%1.111+24%5.879-77%
Pb Ratio0.461-13%0.5200.617-16%0.695-25%0.700-26%0.661-21%
Pe Ratio-14.468+11%-16.297-10.666-35%-20.520+26%-0.767-95%-0.812-95%
Price Per Share0.435-13%0.4900.605-19%0.675-27%0.677-28%0.688-29%
Price To Free Cash Flow Ratio-5.929+11%-6.67917.187-139%-6.632-1%44.286-115%23.707-128%
Price To Total Gains Ratio86.932-13%97.92377.506+26%87.372+12%309.706-68%194.465-50%
Quick Ratio--0.2452.019-88%2.215-89%2.522-90%2.684-91%
Return On Assets---0.006-0.019+216%0.005-228%-0.003-49%-0.126+1972%
Return On Equity---0.008-0.025+219%0.006-237%-0.004-47%-0.035+340%
Total Gains Per Share--0.005-0.020+498%0.008-41%0.001+341%0.026-81%
Usd Book Value--13672300.80014414863.200-5%14713958.400-7%14746864.320-7%13399174.400+2%
Usd Book Value Change Per Share--0.004-0.014+498%0.006-41%0.001+341%0.019-81%
Usd Book Value Per Share--0.6850.712-4%0.707-3%0.702-2%0.652+5%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.018+225%0.008-172%-0.001-82%-0.043+685%
Usd Free Cash Flow---265862.400352848.800-175%-226818.400-15%341081.120-178%-653376.622+146%
Usd Free Cash Flow Per Share---0.0130.017-177%-0.011-16%0.016-186%-0.034+158%
Usd Free Cash Flow To Equity Per Share---0.0230.008-368%-0.027+20%0.001-1865%0.015-249%
Usd Market Cap6174769.738-15%7102850.9498907164.977-20%10210656.195-30%10342000.035-31%10224859.846-31%
Usd Price Per Share0.316-13%0.3560.439-19%0.490-27%0.492-28%0.500-29%
Usd Profit---108960.000-360657.600+231%95703.200-214%-24407.040-78%-809835.111+643%
Usd Revenue--3432240.0003181995.200+8%4272140.000-20%3479201.760-1%2609995.556+32%
Usd Total Gains Per Share--0.004-0.014+498%0.006-41%0.001+341%0.019-81%
 EOD+2 -6MRQTTM+20 -12YOY+9 -245Y+12 -2010Y+21 -11

3.2. Fundamental Score

Let's check the fundamental score of Crescita Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.468
Price to Book Ratio (EOD)Between0-10.461
Net Profit Margin (MRQ)Greater than0-0.032
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.245
Current Ratio (MRQ)Greater than13.801
Debt to Asset Ratio (MRQ)Less than10.235
Debt to Equity Ratio (MRQ)Less than10.307
Return on Equity (MRQ)Greater than0.15-0.008
Return on Assets (MRQ)Greater than0.05-0.006
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Crescita Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.499
Ma 20Greater thanMa 500.432
Ma 50Greater thanMa 1000.426
Ma 100Greater thanMa 2000.448
OpenGreater thanClose0.430
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets24,598
Total Liabilities5,776
Total Stockholder Equity18,822
 As reported
Total Liabilities 5,776
Total Stockholder Equity+ 18,822
Total Assets = 24,598

Assets

Total Assets24,598
Total Current Assets18,487
Long-term Assets6,111
Total Current Assets
Cash And Cash Equivalents 9,385
Net Receivables 1,190
Inventory 6,125
Total Current Assets  (as reported)18,487
Total Current Assets  (calculated)16,700
+/- 1,787
Long-term Assets
Property Plant Equipment 1,846
Long Term Investments 358
Intangible Assets 1,993
Long-term Assets  (as reported)6,111
Long-term Assets  (calculated)4,197
+/- 1,914

Liabilities & Shareholders' Equity

Total Current Liabilities4,864
Long-term Liabilities912
Total Stockholder Equity18,822
Total Current Liabilities
Other Current Liabilities 100
Total Current Liabilities  (as reported)4,864
Total Current Liabilities  (calculated)100
+/- 4,764
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,254
Long-term Liabilities  (as reported)912
Long-term Liabilities  (calculated)1,254
+/- 342
Total Stockholder Equity
Total Stockholder Equity (as reported)18,822
Total Stockholder Equity (calculated)0
+/- 18,822
Other
Capital Stock54,341
Common Stock Shares Outstanding 19,955
Net Invested Capital 18,822
Net Working Capital 13,623
Property Plant and Equipment Gross 4,457



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
> Total Assets 
0
0
0
1,188
34,140
30,899
50,199
43,018
37,000
35,555
31,219
22,565
26,078
23,858
24,780
27,565
28,923
31,534
32,537
26,837
26,607
23,472
27,791
26,831
28,696
27,740
28,023
28,923
29,415
27,793
27,711
28,484
27,841
26,529
25,371
24,598
24,59825,37126,52927,84128,48427,71127,79329,41528,92328,02327,74028,69626,83127,79123,47226,60726,83732,53731,53428,92327,56524,78023,85826,07822,56531,21935,55537,00043,01850,19930,89934,1401,188000
   > Total Current Assets 
0
0
0
1,108
34,079
30,812
29,106
24,372
20,394
19,196
14,841
12,165
15,968
14,014
15,128
16,692
17,502
19,799
21,480
15,922
16,284
15,051
20,079
19,399
19,898
19,285
19,016
20,092
20,870
19,730
20,049
20,516
20,405
19,606
18,813
18,487
18,48718,81319,60620,40520,51620,04919,73020,87020,09219,01619,28519,89819,39920,07915,05116,28415,92221,48019,79917,50216,69215,12814,01415,96812,16514,84119,19620,39424,37229,10630,81234,0791,108000
       Cash And Cash Equivalents 
0
0
0
478
32,594
29,970
15,031
9,807
5,221
4,112
8,755
6,997
9,455
9,094
8,213
8,589
10,879
11,689
13,005
9,268
9,334
9,265
13,856
14,281
13,944
13,083
12,236
11,331
11,742
10,502
10,738
8,238
10,275
10,226
10,021
9,385
9,38510,02110,22610,2758,23810,73810,50211,74211,33112,23613,08313,94414,28113,8569,2659,3349,26813,00511,68910,8798,5898,2139,0949,4556,9978,7554,1125,2219,80715,03129,97032,594478000
       Short-term Investments 
0
0
0
0
0
0
8,551
8,551
8,551
8,551
61
61
61
61
41
51
61
61
61
61
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000616161615141616161618,5518,5518,5518,551000000
       Net Receivables 
0
0
0
254
1,096
407
1,746
2,271
1,860
2,020
1,101
1,636
2,812
1,649
3,643
5,132
3,208
3,855
3,856
2,583
2,884
1,610
1,997
1,364
2,200
1,929
1,201
3,602
3,533
3,682
3,729
6,239
4,253
3,782
2,483
1,190
1,1902,4833,7824,2536,2393,7293,6823,5333,6021,2011,9292,2001,3641,9971,6102,8842,5833,8563,8553,2085,1323,6431,6492,8121,6361,1012,0201,8602,2711,7464071,096254000
       Other Current Assets 
0
0
0
2
332
399
480
761
439
308
921
367
426
241
352
273
377
513
401
287
286
162
364
297
222
339
596
622
640
612
591
393
423
272
420
0
04202724233935916126406225963392222973641622862874015133772733522414263679213084397614803993322000
   > Long-term Assets 
0
0
0
80
61
87
21,093
18,646
16,606
16,359
16,378
10,400
10,110
9,844
9,652
10,873
11,421
11,735
11,057
10,915
10,323
8,421
7,712
7,432
8,798
8,455
9,007
8,831
8,545
8,063
7,662
7,968
7,436
6,923
6,558
6,111
6,1116,5586,9237,4367,9687,6628,0638,5458,8319,0078,4558,7987,4327,7128,42110,32310,91511,05711,73511,42110,8739,6529,84410,11010,40016,37816,35916,60618,64621,093876180000
       Property Plant Equipment 
0
0
0
80
61
87
788
810
796
774
759
708
661
638
690
708
1,472
1,448
1,383
1,181
1,092
1,017
904
786
2,622
2,528
2,478
2,576
2,598
2,502
2,360
2,308
2,151
1,995
1,864
1,846
1,8461,8641,9952,1512,3082,3602,5022,5982,5762,4782,5282,6227869041,0171,0921,1811,3831,4481,472708690638661708759774796810788876180000
       Goodwill 
0
0
0
0
0
0
8,364
7,997
6,195
6,195
5,219
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000005,2196,1956,1957,9978,364000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
330
338
326
309
308
342
350
359
368
358
35836835935034230830932633833000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
10,541
9,839
9,615
9,390
10,400
9,692
9,449
9,206
8,962
8,719
8,476
8,174
7,873
7,571
7,270
5,050
4,749
4,614
4,395
4,177
3,958
3,740
3,522
3,303
3,085
2,866
2,648
2,429
2,211
1,993
1,9932,2112,4292,6482,8663,0853,3033,5223,7403,9584,1774,3954,6144,7495,0507,2707,5717,8738,1748,4768,7198,9629,2069,4499,69210,4009,3909,6159,83910,541000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,446
1,473
458
214
2,163
1,961
2,354
2,059
2,032
1,781
1,750
2,241
2,177
2,099
1,949
1,909
455
289
2,140
196
0
01962,1402894551,9091,9492,0992,1772,2411,7501,7812,0322,0592,3541,9612,1632144581,4731,446000000000000000
> Total Liabilities 
0
0
0
4,554
3,606
3,387
19,350
16,210
15,108
13,147
9,932
9,458
9,816
8,199
8,709
8,558
9,575
9,861
10,918
5,729
6,010
5,927
6,005
5,698
7,973
7,679
8,517
8,397
9,391
7,865
7,735
7,388
6,992
5,938
6,256
5,776
5,7766,2565,9386,9927,3887,7357,8659,3918,3978,5177,6797,9735,6986,0055,9276,0105,72910,9189,8619,5758,5588,7098,1999,8169,4589,93213,14715,10816,21019,3503,3873,6064,554000
   > Total Current Liabilities 
0
0
0
4,519
3,606
3,387
6,971
7,734
7,964
6,304
5,070
5,861
6,172
4,760
5,392
5,644
4,494
4,812
5,917
4,343
4,740
4,731
4,882
4,618
5,073
5,800
6,721
6,725
7,808
6,370
6,329
6,057
5,759
4,804
5,223
4,864
4,8645,2234,8045,7596,0576,3296,3707,8086,7256,7215,8005,0734,6184,8824,7314,7404,3435,9174,8124,4945,6445,3924,7606,1725,8615,0706,3047,9647,7346,9713,3873,6064,519000
       Short-term Debt 
0
0
0
0
0
0
386
723
915
989
27
1,139
1,139
1,139
1,306
1,556
324
333
342
358
368
378
389
297
343
1,307
1,328
1,343
1,359
375
379
405
410
0
0
0
0004104053793751,3591,3431,3281,3073432973893783683583423333241,5561,3061,1391,1391,13927989915723386000000
       Short Long Term Debt 
0
0
0
0
0
0
0
8,164
8,059
7,832
27
1,139
1,139
1,139
1,306
1,556
324
0
0
0
0
0
0
0
0
954
965
976
988
0
0
0
0
0
0
0
0000000988976965954000000003241,5561,3061,1391,1391,139277,8328,0598,1640000000
       Accounts payable 
0
0
0
0
0
0
0
5,782
5,955
4,304
3,846
3,421
3,733
3,131
3,636
3,788
3,870
4,429
5,525
3,935
4,322
4,303
4,443
4,271
4,680
4,443
5,343
5,327
6,399
5,945
5,900
5,591
0
4,340
0
0
004,34005,5915,9005,9456,3995,3275,3434,4434,6804,2714,4434,3034,3223,9355,5254,4293,8703,7883,6363,1313,7333,4213,8464,3045,9555,7820000000
       Other Current Liabilities 
0
0
0
4,519
3,606
3,387
6,585
7,011
7,049
5,315
5,043
4,722
5,033
490
4,086
300
300
50
50
50
50
50
50
4,321
4,730
4,493
5,393
5,382
6,449
5,995
5,950
5,652
5,349
50
50
100
10050505,3495,6525,9505,9956,4495,3825,3934,4934,7304,3215050505050503003004,0864905,0334,7225,0435,3157,0497,0116,5853,3873,6064,519000
   > Long-term Liabilities 
0
0
0
35
0
0
12,379
8,476
7,144
6,843
4,862
3,597
3,644
3,439
3,317
2,914
5,081
5,049
5,001
1,386
1,270
1,196
1,123
1,080
2,900
1,879
1,796
1,672
1,583
1,495
1,406
1,331
1,233
1,134
1,033
912
9121,0331,1341,2331,3311,4061,4951,5831,6721,7961,8792,9001,0801,1231,1961,2701,3865,0015,0495,0812,9143,3173,4393,6443,5974,8626,8437,1448,47612,3790035000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,980
4,907
4,832
1,190
1,104
1,015
923
933
2,745
1,710
1,618
1,525
1,430
1,335
1,239
1,208
1,104
999
892
0
08929991,1041,2081,2391,3351,4301,5251,6181,7102,7459339231,0151,1041,1904,8324,9074,9800000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
1,035
0
0
597
422
446
218
239
61
101
142
169
196
166
181
200
147
155
169
178
147
153
160
167
123
0
135
0
0
00135012316716015314717816915514720018116619616914210161239218446422597001,0350000000
> Total Stockholder Equity
0
0
0
-3,366
30,534
27,512
30,849
26,808
21,892
22,408
21,287
13,107
16,262
15,659
16,071
19,007
19,348
21,673
21,619
21,108
20,597
17,545
21,786
21,133
20,723
20,061
19,506
20,526
20,024
19,928
19,976
21,096
20,849
20,591
19,115
18,822
18,82219,11520,59120,84921,09619,97619,92820,02420,52619,50620,06120,72321,13321,78617,54520,59721,10821,61921,67319,34819,00716,07115,65916,26213,10721,28722,40821,89226,80830,84927,51230,534-3,366000
   Common Stock
0
0
0
0
51,613
51,613
0
55,646
55,646
55,646
55,694
55,694
59,214
59,220
59,220
59,220
59,220
59,220
58,652
58,422
58,184
58,184
58,184
58,184
58,084
58,084
58,324
58,084
57,768
57,384
56,613
56,304
56,304
56,304
55,350
0
055,35056,30456,30456,30456,61357,38457,76858,08458,32458,08458,08458,18458,18458,18458,18458,42258,65259,22059,22059,22059,22059,22059,21455,69455,69455,64655,64655,646051,61351,6130000
   Retained Earnings Total Equity000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
1,059
1,171
1,191
1,169
1,164
1,166
1,145
1,146
1,174
1,151
1,141
1,131
810
1,095
1,148
1,139
1,145
1,137
1,139
1,141
1,046
1,051
1,052
1,051
1,148
1,152
1,153
1,151
1,134
1,132
0
0
0
0001,1321,1341,1511,1531,1521,1481,0511,0521,0511,0461,1411,1391,1371,1451,1391,1481,0958101,1311,1411,1511,1741,1461,1451,1661,1641,1691,1911,1711,059000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,253
1,317
1,752
1,948
2,177
2,208
2,239
2,273
2,394
2,443
2,549
2,769
3,053
3,377
4,003
4,271
4,299
4,321
5,082
0
05,0824,3214,2994,2714,0033,3773,0532,7692,5492,4432,3942,2732,2392,2082,1771,9481,7521,3171,2530000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-4,425
0
37
56,722
56,784
56,861
56,898
56,423
56,472
60,074
60,142
60,195
1,120
1,253
1,317
1,752
1,948
2,177
2,208
2,239
2,273
2,394
2,443
2,549
2,769
3,053
3,377
4,003
4,271
4,299
1,133
1,132
0
01,1321,1334,2994,2714,0033,3773,0532,7692,5492,4432,3942,2732,2392,2082,1771,9481,7521,3171,2531,12060,19560,14260,07456,47256,42356,89856,86156,78456,722370-4,425000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue17,522
Cost of Revenue-7,158
Gross Profit10,36410,364
 
Operating Income (+$)
Gross Profit10,364
Operating Expense-19,478
Operating Income-1,956-9,114
 
Operating Expense (+$)
Research Development699
Selling General Administrative10,115
Selling And Marketing Expenses-
Operating Expense19,47810,814
 
Net Interest Income (+$)
Interest Income507
Interest Expense-85
Other Finance Cost-0
Net Interest Income422
 
Pretax Income (+$)
Operating Income-1,956
Net Interest Income422
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,530-1,960
EBIT - interestExpense = -85
-1,986
-1,901
Interest Expense85
Earnings Before Interest and Taxes (EBIT)--1,445
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,530
Tax Provision-456
Net Income From Continuing Ops-1,986-1,986
Net Income-1,986
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net4-422
 

Technical Analysis of Crescita Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Crescita Therapeutics Inc. The general trend of Crescita Therapeutics Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Crescita Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Crescita Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.455 < 0.455 < 0.49.

The bearish price targets are: 0.42 > 0.42 > 0.42.

Tweet this
Crescita Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Crescita Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Crescita Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Crescita Therapeutics Inc. The current macd is 0.00051662.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Crescita Therapeutics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Crescita Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Crescita Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Crescita Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCrescita Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Crescita Therapeutics Inc. The current adx is 18.71.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Crescita Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Crescita Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Crescita Therapeutics Inc. The current sar is 0.487228.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Crescita Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Crescita Therapeutics Inc. The current rsi is 54.50. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Crescita Therapeutics Inc Daily Relative Strength Index (RSI) ChartCrescita Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Crescita Therapeutics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Crescita Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Crescita Therapeutics Inc Daily Stochastic Oscillator ChartCrescita Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Crescita Therapeutics Inc. The current cci is 4.53514739.

Crescita Therapeutics Inc Daily Commodity Channel Index (CCI) ChartCrescita Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Crescita Therapeutics Inc. The current cmo is 15.80.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Crescita Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartCrescita Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Crescita Therapeutics Inc. The current willr is -57.14285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Crescita Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Crescita Therapeutics Inc Daily Williams %R ChartCrescita Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Crescita Therapeutics Inc.

Crescita Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Crescita Therapeutics Inc. The current atr is 0.01026652.

Crescita Therapeutics Inc Daily Average True Range (ATR) ChartCrescita Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Crescita Therapeutics Inc. The current obv is -135,492.

Crescita Therapeutics Inc Daily On-Balance Volume (OBV) ChartCrescita Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Crescita Therapeutics Inc. The current mfi is 45.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Crescita Therapeutics Inc Daily Money Flow Index (MFI) ChartCrescita Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Crescita Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Crescita Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Crescita Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.499
Ma 20Greater thanMa 500.432
Ma 50Greater thanMa 1000.426
Ma 100Greater thanMa 2000.448
OpenGreater thanClose0.430
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Crescita Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Crescita Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Crescita Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Crescita Therapeutics Inc

I send you an email if I find something interesting about Crescita Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Crescita Therapeutics Inc.

Receive notifications about Crescita Therapeutics Inc in your mailbox!